Concordia Compass
Suzanne VyvodaArchitecting Cohesion Across Modern Life Sciences Strategy. Systems. Substance.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 40 | Founded | a year ago | Last Issue | 7 days ago |
| Active | |||||
Read this Newsletter
concordiacompass.substack.comLatest Issues
From Citrus to Cell Therapy: Why Clinical Trials Day Still Matters
Subscribe now
Most people in drug development know Clinical Trials Day is May 20.
Fewer know why.
In 1747, Scottish naval surgeon James Lind began what is widely recognized as one of the first controlled clinical trials aboard HMS...
Everyone Wants Innovation. No One Wants to Own the Risk
Concordia Compass is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.
Most clinical trial technology doesn’t fail because it’s bad.
It fails because no one wants...
Before There Is Data, There Is Belief
Subscribe now
Every clinical trial begins with an act of optimism.
Before the first patient is enrolled. Before the first site opens. Before anyone knows whether the science will hold, someone decides this might be worth trying.
A scient...
The Trial Didn’t Fail. It Was Designed to Struggle
Subscribe now
The First Signal
The first time you see it, it doesn’t look like failure.
It looks like a coordinator pausing.
You’re on a site initiation visit, walking through the schedule of assessments together. The documen...
What the FDA Actually Says About AI (and What It Doesn’t)
Most people assume FDA regulation is what’s slowing the use of AI in clinical trials.
It isn’t.
The FDA has already created space for AI.
But that space is not tightly defined.
And that distinction matters.
How the...
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Concordia Compass.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
20 years in operations across the clinical trials ecosystem. I write about how trials actually work and how medicines move from pipeline to patients.
Frequently Asked Questions
How can I access the email archive for Concordia Compass?
You can find recent issues that have been published by Concordia Compass on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Concordia Compass have?
To see how many people subscribe to Concordia Compass, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Concordia Compass?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Concordia Compass as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Concordia Compass?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Concordia Compass using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Concordia Compass?
Scroll up to where it says Related Newsletters to see other publications like Concordia Compass. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Concordia Compass?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.